10 aug 2021
CPhI North America 2021
Emergent Biosolutions

Emergent Biosolutions

Exhibitor at CPhI North America 2021 stand stand 801

About us

Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Since 1998, Emergent has been a go-to source for solving some of the most complex and critical challenges in public health. From initial process and analytical development, to clinical through commercial manufacturing supply, our experienced CDMO team can help guide your project successfully through all stages of the drug development lifecycle.

We can support a wide range of platforms and technologies including, mammalian, microbial, viral, plasma, and advanced therapies to support preclinical through commercial manufacturing. 

Our CDMO capabilities include: 

  • Development Services
  • Drug Substance
  • Drug Product Manufacturing & Packaging/Labeling

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: Analytical Development |Antibodies |Biomanufacturing More

Products featured at CPhI North America 2021

Emergent Biosolutions

Event information

CPhI North America 2021

August 10-12 2021 Philadelphia, USA Visit us at stand 801